Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

BlueNord: Successful Closing of USD 1.4 Billion Reserve Based Lending Facility

Oslo, 12 June 2024: BlueNord ASA (“BlueNord” or the “Company”) refers to the stock exchange announcement on 31 May 2024 regarding a new USD 1.4 billion Reserve Based Lending Facility (“RBL” or “Facility”) and is pleased to announce the successful closing of the Facility.  The new RBL will replace BlueNord's existing USD 1.1 billion Facility and extends maturity to December 2029. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. *** Contact:Cathrine Torgersen, Chief Corporate Affairs OfficerPhone: +47

Pihlajalinna Oyj: Acquisition of own shares on June 12, 2024

Pihlajalinna Oyj: Acquisition of own shares on June 12, 2024 Pihlajalinna Oyj’s stock exchange release on June 12, 2024, at 07:00 p.m. EET Date June 12, 2024Exchange transaction BuyShare trading code PIHLISAmount, shares 550Average price/share (EUR) 9.4212Total cost (EUR) 5,181.66 After the acquisitions Pihlajalinna Oyj holds a total of 133,544 treasury shares. ON BEHALF OF PIHLAJALINNA OYJ Danske Bank A/S, Finland Branch  Antti Väliaho                        Jonathan Nyberg Additional Information

#24-213 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-212 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

Holding(s) in Company

TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB0003328555 Issuer Name Fidelity Japan Trust PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name City of London Investment Management Company Limited City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s)

EQL Pharma AB has been approved for listing on Nasdaq Stockholm

Nasdaq Stockholm’s listing committee has today announced that it considers that EQL Pharma AB ("EQL Pharma" or the "Company") meets the applicable listing requirements and that they will approve the application for admission to trading of the Company’s shares on Nasdaq Stockholm Main Market subject to customary conditions being met, including the approval and registration of a prospectus by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and the fulfilment of the distribution requirement for the Company’s shares. The first day of trading on Nasdaq Stockholm is expected to

Exercise of Camurus’ employee stock options program 2021/2024

Lund, Sweden — 12 June 2024 — As of 12 June 2024, a total of 673,200 options in Camurus AB’s employee stock options program (ESOP) 2021/2024 have been exercised for the corresponding number of shares, at an exercise price of SEK 263.50 per share. Through the exercise of the employee stock options, Camurus receives a total of SEK 177,388,200. A number of employees and senior executives of Camurus have participated in two forms of cashless exercise, where shares have been sold either in such number that was required to finance the subscription of new shares and taxes related to the ESOP

Director/PDMR Shareholding

12 June 2024 Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that, on 10 June 2024, it was notified by Pascal Soriot, Chief Executive Officer, that, on 10 June 2024, Mr Soriot ceased to be beneficially interested in 297,418 Ordinary Shares of $0.25 each in the Company, following the gift of those shares to family members for nil consideration. Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European

Change in NYAB Plc's holding of treasury shares

NYAB PlcCOMPANY ANNOUNCEMENT12 June 2024 at 17:00Change in NYAB Plc’s holding of treasury shares NYAB Plc announced on 13 May 2024 that it has transferred 1,543,986 shares in the Company, previously held as treasury shares, to participants in NYAB’s share-based incentive plans. Of the transferred shares, 24,663 shares have been returned free of consideration to the Company. NYAB Plc’s total number of shares on 12 June 2024 is 712,993,008, of which 2,480,677 shares are held as treasury shares. Contacts · Investor Relations, NYAB Oyj, ir@nyabgroup.com About NYAB Oyj

STOREBRAND ASA: Capital Reduction completed

In accordance with the purpose of the buy-back programs carried out by Storebrand ASA ("Storebrand") from 29 March 2023 to 22 December 2023, the company's annual general meeting held on 4 April 2024 decided to reduce the company's share capital with NOK 87,625,925 from NOK 2,327,489,330 to NOK 2,239,863,405, by deletion of 17,525,185 shares. The resolution to reduce the share capital was registered with the Norwegian Register of Business Enterprises on 9 April 2024. The subsequent creditor notice period of six weeks has now expired, and the capital reduction has therefore been completed

Celebrated filmmaker returns to Teesside to share career insight

Acclaimed film director, writer and producer Franc Roddam will return to Teesside University to share exclusive insight into his career journey, which took him from our region to Hollywood.Franc, who was born and raised in Norton, is behind some of the best-known moments in British popular culture, including iconic film Quadrophenia and hugely successful television series Auf Wiedersehen, Pet. Audience members can go behind the scenes with Franc, as he talks about his work at the next In Conversation event at Teesside University on Thursday, 20 June, from 6.30pm to 8.00pm at The Hub,

Qred raises its loan limit — aims to provide greater flexibility

Qred, the bank for small businesses, is increasing the maximum amount for business loans. Small business owners can now apply for loans of up to 5 million SEK. Stockholm, June 12, 2024 - Qred, Europe's newest bank, is raising the loan limit for small business owners. Customers can now apply for loans up to 5 million SEK, an increase of 3 million SEK from the previous maximum amount. The increase is part of Qred's ongoing effort to better meet the needs of small business owners and support their business goals. "We have seen increased demand from small business owners for larger

Bulletin from the Annual General Meeting of Metacon AB (publ)

Metacon AB (publ), reg. no. 556724-1616 (the "Company"), has held its Annual General Meeting on 12 June 2024 at Advokatfirman Schjødt at Hamngatan 27 in Stockholm. At the meeting, resolutions were made on the following. Adoption of the accounts and discharge from liabilityThe Annual General Meeting adopted the income statement and balance sheet for the Company and the Group for 2023. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2023. Allocation of profitThe Annual General Meeting resolved, in accordance with the Board of

2.5 GW Mareld Floating Offshore Wind farm in Sweden receives positive recommendation from County Board

Mainstream Renewable Power ("Mainstream"), the pureplay global wind and solar company majority-owned by Aker Horizons ASA, announced that The County Administrative Board of Västra Götaland has proposed that the Government approve Freja Offshore's application to build the Mareld floating offshore wind farm, subject to certain adaptations.Freja Offshore is a 50-50 joint venture between Mainstream Renewable Power and Swedish company Hexicon. Freja Offshore welcomes the announcement, which is a crucial step in delivering the wind farm into commercial operation. Freja Offshore applied to

CS MEDICA Announces Strategic Partnership with OneMed

CS MEDICA Signs with OneMed for Enhanced Distribution and Marketing in DenmarkCS MEDICA is happy to announce a new strategic partnership with OneMed, a leading distributor in the healthcare sector. This collaboration marks a significant step in CS MEDICA's newly adopted B2B2C strategy, which focuses on generating strategic partnerships for enhanced market access while continuing to prioritize its core values in research and development, production, compliance, and insights. As part of the Asker Group, OneMed brings a robust distribution network and a deep understanding of the medical

Project update Vestmanna: Service and inspection of Dragon 12 - demonstration site attracting international study visits

Project Update Vestmanna: Four months of grid-connected operation with the utility-scale Dragon 12 is now followed by service and inspection. Ongoing operations continue to attract visits from international stakeholders and high-level decision-makers.After four months of grid-connected operation, the Dragon 12 was recovered successfully on the 6th of June for onshore inspection and maintenance program. This is the first inspection of the unit, covering all systems and components. The Dragon 12 will be reinstalled when these activities are completed.  One Dragon 4 unit has been installed

Inside information: Profit warning – Konecranes upgrades its profitability guidance for 2024

KONECRANES PLC INSIDE INFORMATION June 12, 2024 at 16:00 EEST   Inside information: Profit warning – Konecranes upgrades its profitability guidance for 2024   Konecranes upgrades its profitability guidance for 2024. During the first five months of the year, Konecranes’ strategy execution has progressed better than initially expected. The company has also continued its effective cost inflation management. As a result, Konecranes now expects its full-year 2024 comparable EBITA margin to improve from the previous year.   Konecranes updated financial guidance for 2024:

Getinge receives U.S. FDA 510(k) clearance for Talis +ACG Clinical Decision Support software, pioneering quality of high-acuity care in US and EU

Getinge has been granted U.S. FDA 510(k) clearance for its innovative clinical decision support software Talis +ACG (Advanced Clinical Guidance), steering in a new era of improving quality of care through promoting compliance with care protocols directly at the bedside in high acuity care environments. Global medtech company Getinge announces the U.S. FDA 510(k) clearance of its Talis +ACG clinical decision support software, including Talis-Anesthesia™, Talis-Perfusion™, Talis-RemoteView™, and Talis-ECMO™ applications. This milestone marks a significant leap forward in supporting

Bulletin from the Annual General Meeting 2024

Spectrumone AB’s Annual General Meeting was held on June 12, 2024 at Vasagatan 10 in Stockholm. Income statement and balance sheet The Annual General Meeting approved the income statement and balance sheet for the Parent Company and the Consolidated Income Statement and Consolidated Balance Sheet for the fiscal year of 2023. Disposal of profit/loss The Annual General Meeting decided that no dividend would be paid for the financial year 2023 and the loss for the year would be transferred as stated in the Annual report. Board The Annual General Meeting gave discharge for the

Repurchase of class C shares for incentive programs

The board of directors of Tobii AB (publ) (“Tobii”) today resolved to repurchase 794,429 outstanding class C shares. Today’s resolution by the board of directors was passed based on the authorisation granted by the annual general meeting held on May 23, 2024. Tobii will repurchase all outstanding C-shares at a purchase price corresponding to the quota value of SEK 0.007257 per share. The class C shares do not entitle to dividends and each share entitles to 1/10 voting right. The purpose of the repurchase is to enable potential future delivery of ordinary shares in accordance with the

There are no items matching the current filter
There are no more items matching the current filter
Back to top